Secondary Liver Cancer Prognosis Life Expectancy

Secondary Liver cancer Prognosis Life Expectancy

Secondary liver cancer prognosis life expectancy - Where cancer begins is called primary cancer. In case some of the cells out from the cancer primer, they can move through the bloodstream or lymphatic system to other parts of the body, where they can form new tumors. This is called secondary cancer. Cancer secondary also is known as the metastasis (pronounced met-ass-ta-sees). Cancer is the second made from the type of cells the same as primary cancer. If your cancer started in your lung and has spread to your liver, the area of cancer in the liver is composed of cells-cell lung cancer.

This is different from having cancer that first starts in the liver (liver cancer primer). In such cases, cancer consists of cells of the liver become cancerous. This is important because primary cancer tells doctors what kind of treatment you need. (See also: Secondary Liver Cancer Survival Rates)

Prognosis of liver cancer depends on their stage of cancer, liver damage and whether there is cirrhosis of the liver. That is, the prognosis is the best occur in patients with liver cancer at an early stage, without the consequence of liver function and no cirrhosis. The level of Alpha-fetoprotein is also prognostic, inversely proportional.

In more than 70% of cases, hepatocarcinoma diagnosed as a disease that cannot be treated or further, and therefore, with a very poor prognosis. The survival rate of untreated per year is 29%, in 2 years at 18% and at 3 years at only 8%. When the operation is finished, in the early stages, survival 5 years greater than 50%, but there is a risk of recurrence after surgery of over 70% at 5 years. In tumors that cannot be treated with local technique, survival at 5 years can reach 50% only in subjects with liver function better. However, the recurrence rate at 5 years ranges from 80% to 100%. A tumor the most advanced features median survival is short, not exceeding a year.

Secondary Liver cancer Prognosis Life Expectancy

The earlier liver cancer is detected, the better the prognosis and the possibility of healing. In liver cancer, life expectancy mainly depends on the number, size, and position of the tumor, as well as the level of their body. It is also important to find out whether it is cancer of the liver itself, namely the primary, or if it is secondary cancer, namely metastases of the liver. If surgical intervention may occur in liver cancer, the life expectancy in one out of every two that are operated more than five years, if it is secondary cancer, the evolution of the tumor disease of the underlying is also important.

Secondary liver cancer prognosis life expectancy - In many cases (in seven of the ten affected), cancer so advanced at the time of diagnosis, healing that may not happen. If the liver cancer has metastasized (especially to the bones or the lungs), this exacerbates the diagnosis. Without treatment, life expectancy with liver cancer drastically reduced. Of the approach of palliative pure, which is the approach of non-curative, survival time average is six to twelve months. In the case of liver cancer the onset of the end, a rapid diagnosis can also contribute to the increased survival and lifespan remaining may be borne and worthy to be lived. (See also: Liver Cancer Treatment in Ayurveda)

Postoperative care: There is no fixed term for the postoperative exam that should be done in the case of liver cancer. After undergoing surgery, a physical examination is recommended every six months, an ultrasound at the abdomen and liver, as well as the analysis of the protein AFP (tumor marker) in the blood. After the operation of liver cancer aiming at three objectives:
  • To detect early cancer of the liver are repeated and can treat it in the (originative maintainability, for example).
  • Diagnose likely due to the operation and maintainability of the local, as well as accompany the disease, take care of him and, as far as possible, subtracts this.
  • To help the patient with physical, psychic and social.

What is metastatic cancer in the liver? Metastatic liver cancer is a frequent occurrence of a variety of cancers and is a common cause of death of advanced forms of neoplasms.  Cancer of the gastrointestinal tract, lung, eye melanoma, neuroendocrine tumors are the most common neoplasms that cause metastases in the liver. Colorectal cancer due to frequency and therapeutic developments is the most interesting neoplasm with liver metastases and will be the subject of this study Article.

Apart from colorectal cancer, there are other primary hotplates that choose the liver for metastasis. Some of these are neuroendocrine tumors, pancreatic cancer, stomach, breast, lung, eye melanoma, gynecological cancers and kidney and bladder cancers. Secondary liver cancer prognosis life expectancy - Of these, neuroendocrine tumors primarily have the potential to benefit from surgical intervention in case of metastases to the liver. Their basic treatment is pharmaceutical therapy.

What is the cause of the high incidence of hepatic metastases in the liver? The increased incidence of hepatic metastases from colorectal cancer is largely due to the specificity of blood flow from the large intestine to the liver (portal vein) and is dependent on the degree of colon wall filtration and the lymph node involvement. The prevalence is that the incidence is higher in adenocarcinoma of the colon compared with rectal adenocarcinoma.

In particular, the incidence of colorectal cancer in Europe is 420,000 cases per year and in Greece 4,000 per year. The mortality rate in Europe is 210,000 deaths per year, while in Greece 2500 per year. 25% of patients show metastasis at diagnosis while 40-50% during the disease. Of these, 10-20% are surgical metastases whereas 80-90% are non-operative and the main treatment is chemotherapy. One of the main goals of chemotherapy is the conversion of unresolved metastases into surgical. This is achieved by reducing their size and is achieved in 15 - 30% of cases. Secondary liver cancer prognosis life expectancy - This translates into a 5-year survival of 40% and 10 years of 25%, meaning that a significant number of patients are cured. The corresponding percentages in non-operable liver metastases at 5 years are 10% 3.